These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9828023)

  • 21. Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay.
    Casonato A; Fabris F; Pontara E; Cattini MG; Zocca N; Gallinaro L; Girolami A; Pagnan A
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):296-304. PubMed ID: 16959682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse of thrombotic thrombocytopenic purpura associated with decreased VWF cleaving activity.
    Anstadt MP; Carwile JM; Guill CK; Conklin LD; Soltero ER; Lucci A; Kroll MH
    Am J Med Sci; 2002 May; 323(5):281-4. PubMed ID: 12018674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Von Willebrand factor regulates complement on endothelial cells.
    Noone DG; Riedl M; Pluthero FG; Bowman ML; Liszewski MK; Lu L; Quan Y; Balgobin S; Schneppenheim R; Schneppenheim S; Budde U; James P; Atkinson JP; Palaniyar N; Kahr WH; Licht C
    Kidney Int; 2016 Jul; 90(1):123-34. PubMed ID: 27236750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Von Willebrand factor: molecular size and functional activity.
    Furlan M
    Ann Hematol; 1996 Jun; 72(6):341-8. PubMed ID: 8767102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Tsai HM
    J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
    Moake JL
    Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Mannucci PM; Lombardi R; Lattuada A; Ruggenenti P; Viganò GL; Barbui T; Remuzzi G
    Blood; 1989 Aug; 74(3):978-83. PubMed ID: 2665869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine.
    Moake JL; Rudy CK; Troll JH; Schafer AI; Weinstein MJ; Colannino NM; Hong SL
    Am J Hematol; 1985 Sep; 20(1):73-9. PubMed ID: 3875285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    George JN
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura.
    Du VX; van Os G; Kremer Hovinga JA; Dienava-Verdoold I; Wollersheim J; Ruggeri ZM; Fijnheer R; de Groot PG; de Laat B
    Br J Haematol; 2012 Oct; 159(1):94-103. PubMed ID: 22881339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura.
    Pimanda JE; Chesterman CN; Hogg PJ
    Eur J Haematol; 2003 Apr; 70(4):257-62. PubMed ID: 12656756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.
    Lian EC
    Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura.
    Karpman D; Holmberg L; Jirgård L; Lethagen S
    Kidney Int; 1996 Jan; 49(1):190-9. PubMed ID: 8770967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. von Willebrand factor abnormalities and endothelial cell perturbation in a patient with acute thrombotic thrombocytopenic purpura.
    Moake JL; Rudy CK; Troll JH; Weinstein MJ; Colannino NM; Hong SL; Koutcher JA; Melaragno AJ; Manner CE
    Am J Med Sci; 1986 Jan; 291(1):47-50. PubMed ID: 3079954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. alpha 1-Antitrypsin therapy in a case of thrombotic thrombocytopenic purpura.
    Galbusera M; Ruggenenti P; Noris M; Burnouf-Radosevich M; Benigni A; Mannucci PM; Remuzzi G
    Lancet; 1995 Jan; 345(8944):224-5. PubMed ID: 7823715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Baker KR; Moake JL
    Curr Opin Pediatr; 2000 Feb; 12(1):23-8. PubMed ID: 10676770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.